HeimHLN • LON
add
Haleon PLC
Við síðustu lokun
371,70 GBX
Dagbil
368,20 GBX - 373,40 GBX
Árabil
308,37 GBX - 400,65 GBX
Markaðsvirði
41,09 ma. USD
Meðalmagn
16,56 m.
V/H-hlutf.
27,99
A/V-hlutfall
1,68%
Aðalkauphöll
LON
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (GBP) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 2,78 ma. | -0,64% |
Rekstrarkostnaður | 1,04 ma. | -5,01% |
Nettótekjur | 485,00 m. | 32,88% |
Hagnaðarhlutfall | 17,45 | 33,82% |
Hagnaður á hvern hlut | 0,05 | 0,40% |
EBITDA | 752,75 m. | 3,94% |
Virkt skatthlutfall | 20,29% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (GBP) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 531,00 m. | 8,37% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 16,71 ma. | — |
Útistandandi hlutabréf | 9,17 ma. | — |
Eiginfjárgengi | 2,04 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 6,84% | — |
Peningaflæði
Breyting á handbæru fé
| (GBP) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 485,00 m. | 32,88% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.
Sir Dave Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. Wikipedia
Stofnsett
18. júl. 2022
Vefsvæði
Starfsfólk
25.408
